Literature DB >> 7054243

Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci.

H A Verbrugh, J R Hoidal, B Y Nguyen, J Verhoef, P G Quie, P K Peterson.   

Abstract

Human alveolar macrophages (AM) have recently been reported to ingest and kill a strain of Staphylococcus (502A) in the absence of opsonins. To further investigate the mechanism of non-opsonic recognition, we studied phagocytosis of 23 clinical and laboratory strains of S. aureus and Staphylococcus epidermidis by AM, and by blood polymorphonuclear leukocytes (PMN) and monocytes (MN). In the absence of opsonins, AM phagocytized 18 protein A-positive but not 5 protein A-negative strains of staphylococci, and the efficiency of phagocytosis directly correlated with the amount of protein A present in the bacterial cell wall (r = 0.86, P less than 0.001). Furthermore, AM rosetted around protein A-coated Sepharose beads, but not around beads without protein A. In contrast, PMN did not phagocytize nonopsonized staphylococci, and did not rosette around either type of Sepharose. MN phagocytized protein A-positive staphylococci, but much less efficiently than AM, and showed some rosetting around protein A-coated Sepharose. The nature of the AM receptor for protein A-positive staphylococci was studied. The surface of AM was positively stained with fluorescein-conjugated antibody to human IgG, but not with IgA- or IgM-specific conjugates. No such surface-immunoglobulins were detected on PMN, and MN were only weakly positive for surface IgG. Pretreatment of AM with F(ab')2 fragments specific for human IgG (anti-Fc) inhibited subsequent phagocytosis of protein A-positive staphylococci. There was no evidence that the AM surface IgG was aggregated or immunecomplexed. From these studies we conclude that human AM possess cytophilic IgG antibodies, which can function as receptors for phagocytosis of protein A-positive staphylococci.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054243      PMCID: PMC371169          DOI: 10.1172/jci110442

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

2.  Proteolytic degradation of exocrine and serum immunoglobulins.

Authors:  W R Brown; R W Newcomb; K Ishizaka
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

3.  Phagocytosis in subacute bacterial endocarditis. Localization of the primary opsonic site to Fc fragment.

Authors:  P G Quie; R P Messner; R C Williams
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

4.  IgG subclass specificity of human monocyte receptor sites.

Authors:  H Huber; S D Douglas; J Nusbacher; S Kochwa; R E Rosenfield
Journal:  Nature       Date:  1971-02-05       Impact factor: 49.962

5.  Macrophage cytophilic antibody in mice. Differentiation between antigen adherence due to these antibodies and opsoni adherence.

Authors:  I R Tizard
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

6.  Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes.

Authors:  K Ishizaka; H Tomioka; T Ishizaka
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

7.  Properties of antibodies cytophilic for macrophages.

Authors:  A Berken; B Benacerraf
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

8.  Differences in anti-protein A activity among IgG subgroups.

Authors:  G Kronvall; R C Williams
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

Review 9.  Macrophage-cytophilic antibodies and the functions of macrophage-bound immunoglobulins.

Authors:  I R Tizard
Journal:  Bacteriol Rev       Date:  1971-12

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  8 in total

1.  Staphylococcus aureus in chronic and recurrent infections.

Authors:  L Slobodníková; D Kotulová; I Zahradníková
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

2.  Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity.

Authors:  D L Dunn; R A Barke; N B Knight; E W Humphrey; R L Simmons
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

3.  Interaction between human polymorphonuclear leucocytes and Staphylococcus aureus in the presence and absence of opsonins.

Authors:  C M Vandenbroucke-Grauls; H M Thijssen; J Verhoef
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

4.  Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.

Authors:  H van Bronswijk; H A Verbrugh; H C Heezius; J van der Meulen; P L Oe; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

5.  Interaction of Legionella micdadei with human monocytes.

Authors:  D L Weinbaum; R R Benner; J N Dowling; A Alpern; A W Pasculle; G R Donowitz
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

6.  Polyamino acid enhancement of bacterial phagocytosis by human polymorphonuclear leukocytes and peritoneal macrophages.

Authors:  P K Peterson; G Gekker; R Shapiro; M Freiberg; W F Keane
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

7.  Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages.

Authors:  P K Peterson; E Gaziano; H J Suh; M Devalon; L Peterson; W F Keane
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

8.  Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.

Authors:  H A Verbrugh; D A Lee; G R Elliott; W F Keane; J R Hoidal; P K Peterson
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.